drugset / Trial / NCT00608335
Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug
Non-randomizedSingle-groupOpen-labelOther
Summary
Children with fungal infections will be divided into two groups by weight. Children weighing \< 25 kg will receive a higher dose of study medication (per kg body weight) for 10 to 14 days than children weighing \> 25 kg.
Timeline
- Start
- 2007-10-14
- Primary completion
- 2011-09-08
- Completion
- 2011-09-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Micafungin | Peptide | 3 mg/kg | — |
| Subject | Micafungin | Peptide | 4.5 mg/kg | — |